Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Expands Research Facilities as Result of Millennium, Lion Links

Premium

W

OODBRIDGE, Conn.--Bayer said it has begun expanding its research facilities as a direct result of alliances with Millennium Pharmaceuticals and Lion Bioscience, which have given the pharmaceutical company access to genomic and bioinformatics-based research technologies. Bayer expects to spend $80 million to expand its research facilities in West Haven and Orange. Plans include construction of a chemistry research building and a high-throughput screening center. The company expects to hire more than 200 additional chemists and biologists by 2003.

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.